{"disease":{"id":"withdrawal-syndrome","name":"withdrawal syndrome"},"drugs":{"marketed":[{"drug_id":"diazepam","indication_name":"Alcohol withdrawal syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Valium","generic_name":"diazepam","company_name":"Generic (originally Roche)","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Aldo-keto reductase family 1 member C1, Aldo-keto reductase family 1 member C2","drug_class":"Benzodiazepine [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"chlordiazepoxide","indication_name":"Alcohol withdrawal syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chlordiazepoxide Hydrochloride","generic_name":"CHLORDIAZEPOXIDE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Benzodiazepine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"clorazepate","indication_name":"Alcohol withdrawal syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tranxene","generic_name":"clorazepate","company_name":"Ajenat Pharms","drug_phase":"marketed","molecular_target":"GABA-A receptor alpha-1/beta-2/gamma-2","drug_class":"Benzodiazepine","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"clomethiazole","indication_name":"Alcohol withdrawal syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Emineurina","generic_name":"CLOMETHIAZOLE","company_name":"","drug_phase":"discontinued","molecular_target":"GABA-A receptor alpha-1/beta-3/gamma-2","drug_class":"clomethiazole","quality_score":0,"revenue":null,"mechanism":"Emineurina works by enhancing the activity of the neurotransmitter GABA, which helps to calm excessive brain activity."}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04973202","title":"Portrayal of Hospital Alcohol Detoxification in France","phase":"","overall_status":"COMPLETED","enrollment_count":50000,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT04422808","title":"AduLt iatrogEnic withdRawal sTudy in the ICU (ALERT-ICU)","phase":"","overall_status":"COMPLETED","enrollment_count":2437,"lead_sponsor_name":"Wilkes University","has_results":false},{"nct_id":"NCT04057820","title":"Eating, Sleeping, Consoling for Neonatal Withdrawal (ESC-NOW): a Function-Based Assessment and Management Approach","phase":"NA","overall_status":"COMPLETED","enrollment_count":1305,"lead_sponsor_name":"Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program","has_results":true},{"nct_id":"NCT07278375","title":"Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome","phase":"","overall_status":"RECRUITING","enrollment_count":796,"lead_sponsor_name":"HELP for NOWS Consortium","has_results":false},{"nct_id":"NCT05980260","title":"Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":626,"lead_sponsor_name":"HELP for NOWS Consortium","has_results":false},{"nct_id":"NCT06555679","title":"Evaluation of a Predictive Score for the Onset of Moderate to Severe Alcohol Withdrawal Syndrome, the PAWSS, in a Population of Intensive Care Patients at Brest University Hospital","phase":"","overall_status":"COMPLETED","enrollment_count":403,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT05336656","title":"Assessment of Analgesics and Sedatives in Mechanically Ventilated Patients With COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":353,"lead_sponsor_name":"Wilkes University","has_results":false},{"nct_id":"NCT03235531","title":"Assessment of Valproate on Ethanol Withdrawal","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":210,"lead_sponsor_name":"CAMC Health System","has_results":false},{"nct_id":"NCT06589973","title":"Effect of Clinical and Biochemical Variables Over Morbidity and Mortality in Alcohol Withdrawal Syndrome Patients","phase":"","overall_status":"RECRUITING","enrollment_count":195,"lead_sponsor_name":"Hospital General de Mexico","has_results":false},{"nct_id":"NCT04214834","title":"Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":189,"lead_sponsor_name":"Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program","has_results":true},{"nct_id":"NCT05995535","title":"Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT03918850","title":"Medication Treatment for Opioid Use Disorder in Expectant Mothers","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"T. John Winhusen, PhD","has_results":false},{"nct_id":"NCT03573479","title":"Early Rehabilitation in Critically Ill Children - The PICU Liber8 Study","phase":"","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"McMaster University","has_results":false},{"nct_id":"NCT03971097","title":"The Effect of Self-Forgiveness on Self-Stigma in Addiction.","phase":"NA","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT04834297","title":"Use of SVS Device to Improve Outcomes for Neonatal Opioid Withdrawal Syndrome.","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Tufts Medical Center","has_results":false},{"nct_id":"NCT07316894","title":"IWS Diagnosis Criteria Consensus","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"ELIAS Emergency University Hospital","has_results":false},{"nct_id":"NCT05029401","title":"A Study of Oral Ibogaine in Opioid Withdrawal","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"atai Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03033823","title":"MAGnesium Adjunction in Alcohol Withdrawal Syndrome: a Multicenter Assessment (MAGMA)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT02052440","title":"Preventing Alcohol Withdrawal Syndrome With Oral Baclofen","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":102,"lead_sponsor_name":"Denver Health and Hospital Authority","has_results":true},{"nct_id":"NCT03911466","title":"Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study","phase":"","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"T. John Winhusen, PhD","has_results":false},{"nct_id":"NCT03012815","title":"Gabapentin for Alcohol Withdrawal Syndrome","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Mayo Clinic","has_results":true},{"nct_id":"NCT04049799","title":"Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions","phase":"","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"University of Vermont","has_results":false},{"nct_id":"NCT03911739","title":"Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study","phase":"","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"T. John Winhusen, PhD","has_results":false},{"nct_id":"NCT03374722","title":"Opioid Withdrawal Symptoms in Critically Ill Patients","phase":"","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT05569031","title":"Treatment of Withdrawal Symptoms and Prevention of Relapse in Patients With Tramadol Abuse","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Zagazig University","has_results":false},{"nct_id":"NCT05129020","title":"Neurostimulation to Improve NOWS Outcomes","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":52,"lead_sponsor_name":"Spark Biomedical, Inc.","has_results":false},{"nct_id":"NCT05937594","title":"MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Milton S. Hershey Medical Center","has_results":false},{"nct_id":"NCT03996096","title":"Tyrosine Kinase Inhibitor Withdrawal Syndrome in CML Patients: Observatory Trial Studying the Biological Factors.","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"University Hospital, Caen","has_results":false},{"nct_id":"NCT05883358","title":"Kratom Use Disorder Management Using Clonidine and/or Buprenorphine","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Salem Anaesthesia Pain Clinic","has_results":false},{"nct_id":"NCT03397212","title":"Treatment of Withdrawal Symptoms With NADA Acupuncture in Chronic Pain Patients","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT03645603","title":"Efficacy and Safety of Dexmedetomidine During Weaning From Analgesia and Sedation in PICU (TIP-15-01)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":45,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT05025384","title":"Jackson Pediatric Acupressure for Opioid Tapering","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":true},{"nct_id":"NCT03435614","title":"Signs and Symptoms of Opioid-associated Iatrogenic Withdrawal in Critically Ill Adults","phase":"","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Marc M. Perreault","has_results":true},{"nct_id":"NCT03521960","title":"Buspirone for Opioid Tapering","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT04298853","title":"Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Indiana University","has_results":true},{"nct_id":"NCT03077932","title":"An App to Aid in Transitioning Off Opioid Medication","phase":"NA","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Butler Hospital","has_results":false},{"nct_id":"NCT03608696","title":"Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Thomas Jefferson University","has_results":true},{"nct_id":"NCT03114904","title":"Comparison of the Efficacy of a Protocol for the Withdrawal of Neurosedation From the Usual Strategy in Cerebroses","phase":"NA","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Centre Hospitalier Universitaire, Amiens","has_results":false},{"nct_id":"NCT04104646","title":"CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Chiesi Farmaceutici S.p.A.","has_results":true},{"nct_id":"NCT03788889","title":"Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Santa Barbara Cottage Hospital","has_results":false},{"nct_id":"NCT04455802","title":"Randomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrome (NOWS)","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Women and Infants Hospital of Rhode Island","has_results":false},{"nct_id":"NCT03975192","title":"Neurostimulation for Opiate Withdrawal in the PICU","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Medical College of Wisconsin","has_results":false}],"total":42},"guidelines":[],"source":"Drug Landscape verified database"}